The CAR T-cell therapy ciltacabtagene autoleucel generated a high response rate in patients with multiple myeloma who experienced early clinical relapse or failure to initial therapy.
The CAR T-cell therapy ciltacabtagene autoleucel (cilta-cel; Carvykti) generated a high response rate in patients with multiple myeloma who experienced early clinical relapse or failure to initial therapy, according to data from cohort B of the phase 2 CARTITUDE-2 trial (NCT04133636) presented during the 2022 EHA Congress.1
At a median follow-up of 13.4 months (range, 5.2-21.7), cilta-cel produced an overall response rate (ORR) of 100% (95% CI, 82.4%-100%) in 19 patients; 90% of patients achieved a complete response (CR) or better and 95% had a very good partial response (VGPR) or better. The CAR T-cell therapy resulted in a partial response rate of 5%, and a stringent CR of 63%.
Notably, of the 15 patients with minimal residual disease (MRD)evaluable samples, 93.3% (95% CI, 68.1%-99.8%) achieved negativity with treatment.
"These results are consistent with the responses that we [saw] in the phase 1b/2 CARTITUDE-1 trial [NCT03548207] and in [cohort A of] CARTITUDE-2, Niels W.C.J. van de Donk, MD, study author and hematologist at the VU University Medical Center in Amsterdam, The Netherlands, said in a presentation of the data. The efficacy and safety profile of cilta-cel in high-risk patients with multiple myeloma who experienced early clinical research or treatment failure support the continued exploration of cilta-cel in earlier lines of treatment.
In February 2022, the FDA approved cilta-cel for the treatment of adult patients with relapsed/refractory multiple myeloma following 4 or more prior lines of therapy, including a proteasome inhibitor (PI), an immunomodulatory agent (IMiD), and an anti-CD38 monoclonal antibody, based on results from CARTITUDE-1.2
CARTITUDE-2 aimed to further evaluate cilta-cel in select patient populations with multiple myeloma. Prior data from cohort A of the trial demonstrated that patients who received 2 previous lines of therapy experienced an ORR of 95%, including 79% with a CR or better, and 90% with a VGPR or better.3
Efficacy and safety data from cohort B were presented during the 2022 EHA Congress.
Cohort B enrolled patients with multiple myeloma who experienced early relapse following initial treatment that included a PI and an IMiD. Patients were required to have disease progression per International Myeloma Working Group criteria within 12 months after treatment with autologous stem cell transplantation (ASCT) or from the start of anti-myeloma therapy for patients who did not have an ASCT.4
After screening, patients underwent apheresis followed by bridging therapy, as needed. Five days prior to infusion with cilta-cel, patients received 300 mg/m2 of cyclophosphamide and 30 mg/m2 of fludarabine for 3 days. On day 1 of the study, patients received a cilta-cel infusion with a target dose of 0.75 x 106 CAR-positive viable T cells/kg. Post-infusion assessments were done from day 1 through 100, and posttreatment assessments were conducted from day 101 through the end of the cohort.
The primary end point of CARTITUDE-2 was MRD 10-5 negativity, assessed by next-generation sequencing or next-generation flow. Secondary end points included ORR, duration of response (DOR), time to response, and safety.
Within cohort B, the median age was 58 years (range, 44-67). Most patients were male (73.7%), White (73.7%), had bone marrow plasma cells of less than 60% (78.9%), did not have extramedullary plasmacytomas (84.2%), and did not have a high-risk cytogenetic profile (84.2%). The median time since initial diagnosis was 1.15 years (range, 0.5-1.9), the median prior lines of therapy received was 1 (range, 1-1), and 78.9% of patients underwent prior ASCT. Notably, 21.1% of patients had a triple-class exposure status.
Moreover, 15.8% of patients were triple-class refractory, 78.9% were refractory to their last line of therapy, 78.9% were refractory to lenalidomide (Revlimid), 31.6% were refractory to bortezomib (Velcade), 15.8% were refractory to daratumumab (Darzalex), and 10.5% were refractory to thalidomide.
Additional data showed that the median DOR was not reached with CAR T-cell therapy. The median time to first response was 1.0 month (range, 0.9-9.7), and the median time to best response was 5.1 months (range, 0.9-11.8). The 12-month progression-free survival rate was 89.5% (95% CI, 64.1%-97.3%) with CAR T-cell therapy.
The peak expansion of CAR T cells occurred on day 13 (range, 9-210), and the median CAR T-cell persistence was 77 days (range, 41-222).
Levels of IL-6 and IFN- increased following infusion of cilta-cel, peaking at days 7 through 14 and returning to baseline levels within 2 to 3 months. Notably, the incidence of cytokine release syndrome (CRS) was associated with a higher peak of IL-6 and IFN-.
CRS was reported in 84% of patients; 1 patient had grade 3/4 CRS. The median time to onset of CRS was 8 days (range, 5-11), and the median duration was 3.5 days (range, 1-7). Additionally, 63% of patients received tocilizumab (Actemra) and 21% were given corticosteroids for CRS. This toxicity was resolved in all patients.
Neurotoxicity was reported in 26% of patients, and it had resolved in 3 of 5 patients. One patient experienced grade 1 immune effector cellassociated neurotoxicity syndrome, with a time to onset of 11 days and a duration of 4 days. Another patient experienced grade 3 movement and neurocognitive treatment-emergent adverse effects (MNTs)/parkinsonism that occurred at day 38. Notably, this patient had at least 2 risk factors for MNTs/parkinsonism, and they showed improvement at the time of data cutoff and achieved a CR.
The incidence of MNT and parkinsonism decreased from 6% in CARTITUDE-1 to less than 0.5% after implementation of patient management strategies across the CARTITUDE program, and that includes to administer these patients effective bridging therapy to reduce tumor burden and to treat CRS or icons [early], if it occurs, van de Donk said.
Regarding other safety data, hematologic adverse effects (AEs) of any grade included neutropenia (95%), anemia (58%), thrombocytopenia (58%), lymphopenia (32%), and leukopenia (26%).
Grade 3 or 4 hematologic AEs included neutropenia (90%), anemia (47%), thrombocytopenia (26%), lymphopenia (32%), and leukopenia (26%). Notably, the rate of grade 3/4 cytopenias that did to not improve to grade 2 or less by day 60 was 16% for thrombocytopenia, 11% for lymphopenia, and 11% for neutropenia.
One death occurred on the study, due to progressive disease on day 158. For the 1 patient treated in an outpatient setting, the safety profile of cilta-cel was found to be manageable.
Follow this link:
Cilta-cel Elicits an ORR of 100% in Multiple Myeloma After Early Relapse on Initial Therapy - OncLive
- Wu stem cell medical center hospital introduction video.avi [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Cerebral palsy patient Bianca after stem cell treatment 1.wmv [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Cerebral palsy patient Atillia before stem cell treatment 2.wmv [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- SCI_Celine_French_ifting_her_arms.wmv [Last Updated On: August 5th, 2011] [Originally Added On: August 5th, 2011]
- Cerebral palsy patient Atillia after stem cell treatment 1.wmv [Last Updated On: August 5th, 2011] [Originally Added On: August 5th, 2011]
- MSA_Dezmond_USA_before2.wmv [Last Updated On: August 6th, 2011] [Originally Added On: August 6th, 2011]
- MSA_Dezmond_USA_after1.wmv [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- Parkinson_Jane_Scotland_before1.wmv [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- Cerebral palsy patient Atillia after stem cell treatment 2.wmv [Last Updated On: August 7th, 2011] [Originally Added On: August 7th, 2011]
- Stroke_Li_China_after1.wmv [Last Updated On: August 8th, 2011] [Originally Added On: August 8th, 2011]
- SCI_Cartaze_USA_after1.wmv [Last Updated On: August 9th, 2011] [Originally Added On: August 9th, 2011]
- SCI_Cartaze_USA_after3.wmv [Last Updated On: August 9th, 2011] [Originally Added On: August 9th, 2011]
- Cerebral palsy patient Bianca before stem cell treatment 3.wmv [Last Updated On: August 10th, 2011] [Originally Added On: August 10th, 2011]
- Parkinson_Michael_USA_before1.wmv [Last Updated On: August 13th, 2011] [Originally Added On: August 13th, 2011]
- Cerebral palsy patient Gabor after stem cell treatment 3.1.wmv [Last Updated On: August 14th, 2011] [Originally Added On: August 14th, 2011]
- Parkinson_Michael_USA_before3.wmv [Last Updated On: August 17th, 2011] [Originally Added On: August 17th, 2011]
- Cerebral palsy patient Bianca before stem cell treatment 2.wmv [Last Updated On: August 18th, 2011] [Originally Added On: August 18th, 2011]
- Muscular dystrophy patient_Kleber_Brazil.wmv [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- Cerebral palsy patient Bianca before stem cell treatment 1.wmv [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- Parkinson_David_USA_before1.wmv [Last Updated On: August 19th, 2011] [Originally Added On: August 19th, 2011]
- SCI_Obaidullah_Pakistan.wmv [Last Updated On: August 23rd, 2011] [Originally Added On: August 23rd, 2011]
- Cerebral palsy patient Bianca after stem cell treatment 3.wmv [Last Updated On: August 25th, 2011] [Originally Added On: August 25th, 2011]
- Parkinson_Jane_Scotland_after2.wmv [Last Updated On: August 26th, 2011] [Originally Added On: August 26th, 2011]
- Parkinson_Michael_USA_before2.wmv [Last Updated On: August 27th, 2011] [Originally Added On: August 27th, 2011]
- Multiple sclerosis_Evangelos_Australia_before1.wmv [Last Updated On: September 1st, 2011] [Originally Added On: September 1st, 2011]
- The Board of Governors Heart Stem Cell Center - Cedars-Sinai Medical Center [Last Updated On: September 5th, 2011] [Originally Added On: September 5th, 2011]
- OSU Medical Center Using Stem Cell Therapy for Critical Limb Ischemia Patients [Last Updated On: September 6th, 2011] [Originally Added On: September 6th, 2011]
- Cancer Stem Cells: The Origin of Cancer [Last Updated On: September 7th, 2011] [Originally Added On: September 7th, 2011]
- Human Embryonic stem cell research [Last Updated On: September 8th, 2011] [Originally Added On: September 8th, 2011]
- HIV/AIDS: Spotlight on Stem Cell Research - Loren Leeds [Last Updated On: September 8th, 2011] [Originally Added On: September 8th, 2011]
- Battling and Beating Cancer -- Stem Cell Transplantation Part 1 [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- My first day of apheresis at Duke Medical Center [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- Disease in a Dish: Using Stem Cells to Model Huntington's Disease and Spinal Muscular Atrophy [Last Updated On: September 9th, 2011] [Originally Added On: September 9th, 2011]
- 2010 Stem Cell Transplant Reunion at University of Chicago [Last Updated On: September 11th, 2011] [Originally Added On: September 11th, 2011]
- Reverse Aging - Anti-Aging - Stem Cell Treatment [Last Updated On: September 11th, 2011] [Originally Added On: September 11th, 2011]
- Stem Cell Research Halted At Medical College [Last Updated On: September 12th, 2011] [Originally Added On: September 12th, 2011]
- Stem cell centre in Sri Ramachandra Medical Centre [Last Updated On: September 14th, 2011] [Originally Added On: September 14th, 2011]
- Inside a Heart Stem Cell Clinical Trial - Cedars-Sinai Medical Center [Last Updated On: September 14th, 2011] [Originally Added On: September 14th, 2011]
- Stem Cells and Cardiac Regeneration [Last Updated On: September 16th, 2011] [Originally Added On: September 16th, 2011]
- HIV/AIDS: Spotlight on Stem Cell Research - John Zaia [Last Updated On: September 20th, 2011] [Originally Added On: September 20th, 2011]
- Stem Cells, The Making Of... [Last Updated On: September 23rd, 2011] [Originally Added On: September 23rd, 2011]
- Parkinson's Disease: Spotlight on Stem Cell Research - Jeff Bronstein [Last Updated On: September 24th, 2011] [Originally Added On: September 24th, 2011]
- Life in the Balance: Perspectives on Stem Cell Research [Last Updated On: September 25th, 2011] [Originally Added On: September 25th, 2011]
- Jeanette Montufar - Parkinson's at Integra Medical Center [Last Updated On: September 27th, 2011] [Originally Added On: September 27th, 2011]
- Stem Cell Cures or 21st Century Snake Oil? Part 1 [Last Updated On: September 27th, 2011] [Originally Added On: September 27th, 2011]
- Heart cells grown from human embryonic stem cells [Last Updated On: September 28th, 2011] [Originally Added On: September 28th, 2011]
- Arthritis: Spotlight on Stem Cell Research - Mark Genovese [Last Updated On: October 3rd, 2011] [Originally Added On: October 3rd, 2011]
- Parkinson's Disease Stem Cell Treatment [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Hadassah Medical Center Stem Cell Human Embryonic Stem Cells [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Anti-Aging - Stem Cell Treatment for the Family [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Dr Farjo BBC News 24 interview about new stem cell research and hair transplant surgery [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Stem Cell Cure or 21st Century Snake Oil? Part 3 [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Stem cell miracle by FOX TV on Mar 26 2009 [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Arthritis: Spotlight on Stem Cell Research - Bill Robinson [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Asthma Treated at Integra Medical Center with Stem cells [Last Updated On: October 4th, 2011] [Originally Added On: October 4th, 2011]
- Dr. Lucy Godley on Stem Cell Transplants [Last Updated On: October 5th, 2011] [Originally Added On: October 5th, 2011]
- Cerebral palsy patient Gabor after stem cell treatment 1.wmv [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- SCI_Saber_Egypt.wmv [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- Stroke_Mohd_Saudi_Arabia.wmv [Last Updated On: October 6th, 2011] [Originally Added On: October 6th, 2011]
- SCI_Hammod_Saudi_Arabia.wmv [Last Updated On: October 7th, 2011] [Originally Added On: October 7th, 2011]
- Parkinson_Penny_USA_brfore.wmv [Last Updated On: October 7th, 2011] [Originally Added On: October 7th, 2011]
- Marco Costa MD discusses how stem cells can repair a damaged heart [Last Updated On: October 7th, 2011] [Originally Added On: October 7th, 2011]
- Stem Cell Treatment in Mexico - PlacidWay [Last Updated On: October 8th, 2011] [Originally Added On: October 8th, 2011]
- Parkinson's Disease Stem Cell Treatment - Part 1 [Last Updated On: October 8th, 2011] [Originally Added On: October 8th, 2011]
- Parkinson's Disease Stem Cell Treatment - Part 2 [Last Updated On: October 8th, 2011] [Originally Added On: October 8th, 2011]
- Multiple Sclerosis_Evangelos_Australia_after1.wmv - Video [Last Updated On: October 14th, 2011] [Originally Added On: October 14th, 2011]
- Stem Cell Cures or 21st Century Snake Oil? Part 2 - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- SCI_Christian_Alberto_Alvarado_Arce_Guatemala.wmv - Video [Last Updated On: October 21st, 2011] [Originally Added On: October 21st, 2011]
- Dr. Lucy Godley on Stem Cell Donations for Transplant - Video [Last Updated On: October 26th, 2011] [Originally Added On: October 26th, 2011]
- Transforming stem cells into functioning organ tissue - Video [Last Updated On: October 26th, 2011] [Originally Added On: October 26th, 2011]
- Medical Treatment by Stem Cells Myth or Reality? Episode 1 - Video [Last Updated On: October 27th, 2011] [Originally Added On: October 27th, 2011]
- New advances in the treatment of cancer through stem cell collection and storage for families. - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- Alzheimer's Stem Cell Research Patient Advocate Spotlight: The Faces of Neurodegenerative Disease - Video [Last Updated On: October 29th, 2011] [Originally Added On: October 29th, 2011]
- Harvesting stem cells from horse bone marrow at UT - Video [Last Updated On: October 31st, 2011] [Originally Added On: October 31st, 2011]
- Allison Sass Follow up after Stem Cell therapy - Video [Last Updated On: November 15th, 2011] [Originally Added On: November 15th, 2011]
- SCI_Celine_French_using_computer.wmv - Video [Last Updated On: November 15th, 2011] [Originally Added On: November 15th, 2011]
- Cardiovascular Therapies: Spotlight on Stem Cell Research - Yung-Wei Chi - Video [Last Updated On: November 16th, 2011] [Originally Added On: November 16th, 2011]
- Noel Ordonez ALS treated at IMC stem cell therapy - Video [Last Updated On: December 5th, 2011] [Originally Added On: December 5th, 2011]
- Brain Tumors: Advancing Stem Cell Therapies - 2011 CIRM Grantee Meeting - Video [Last Updated On: December 5th, 2011] [Originally Added On: December 5th, 2011]
- Stem Cell Transplantation | Insights [Last Updated On: December 9th, 2011] [Originally Added On: December 9th, 2011]